p70S6 kinase inhibitors (Sentinel Oncology)

N/A

Report date: 2025/01/26 17:25:38
NME

Base Information

Drug Namep70S6 kinase inhibitors (Sentinel Oncology)
Drug Alias NameS6K-1 inhibitor (Sentinel Oncology)p70S6 kinase inhibitors (Ethical Oncology)FS-115
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action70-kDa ribosomal protein S6 kinases inhibitors
Targets70-kDa ribosomal protein S6 kinases
Therapy Area/IndicationsTriple Negative Breast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSentinel Oncology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSentinel Oncology Ltd
Inactive CompaniesClovis Oncology Italy Srl
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A